Literature DB >> 6601136

Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.

C Walker, F Kristensen, F Bettens, A L deWeck.   

Abstract

PGE2-induced inhibition of the proliferatory response of PHA-stimulated human PBL and Con A-stimulated murine thymocytes was analyzed by flow cytometry. It was found that the activation process (G0-G1a transition) was not influenced by PGE2 over a wide range of concentrations (10(-10) to 10(-6) M), nor was the formation of IL 2 receptors inhibited. Similarly, the viability of human lymphocytes was practically unaltered. In contrast, the IL 2-dependent cell cycle event (G1a-G1b transition), which is required for proliferation, was inhibited in a dose-dependent fashion. The addition of IL 2-containing supernatants to such cultures prevented the PGE2-mediated block in the G1a phase and reconstituted a normal lymphocyte proliferation. Furthermore, lower IL 2 titers were measured in supernatants from PHA-stimulated human PBL treated with PGE2. These findings strongly suggest that PGE2 primarily exerts its inhibitory effect on lymphocyte proliferation through an inhibition of IL 2 production.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601136

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  The effect of a single whole-blood transfusion on cytokine secretion.

Authors:  Y Kalechman; U Gafter; D Sobelman; B Sredni
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

2.  Fish oil feeding enhances lymphocyte proliferation but impairs virus-specific T lymphocyte cytotoxicity in mice following challenge with influenza virus.

Authors:  M Byleveld; G T Pang; R L Clancy; D C Roberts
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  Immunosuppressive actions of prostaglandins and the possible increase in chronic inflammation after cyclo-oxygenase inhibitors.

Authors:  G P Lewis; M L Barrett
Journal:  Agents Actions       Date:  1986-10

4.  Immunosuppression by seminal prostaglandins.

Authors:  A J Quayle; R W Kelly; T B Hargreave; K James
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

5.  Chemical reduction of oxidized human lymphocytes inhibits interleukin 2 production but not induction of interleukin 2 responsiveness.

Authors:  E Roffman; B Sredni; A Smolinsky; M Wilchek
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Effect of cyclosporin A and inhibitors of arachidonic acid metabolism on blood flow and cyclo-oxygenase products in rat skin allografts.

Authors:  T P Fan; G P Lewis
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

7.  Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes.

Authors:  A Clavreul; C L D'hellencourt; C Montero-Menei; G Potron; D Couez
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

8.  Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages.

Authors:  W W Zhong; P A Burke; M E Drotar; S R Chavali; R A Forse
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

9.  Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production.

Authors:  R D Stout; K P Ferguson; Y N Li; D W Lambe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 10.  Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.